David Brott

658 total citations
28 papers, 468 citations indexed

About

David Brott is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, David Brott has authored 28 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Physiology and 5 papers in Immunology. Recurrent topics in David Brott's work include Chronic Kidney Disease and Diabetes (3 papers), Acute Kidney Injury Research (3 papers) and Nitric Oxide and Endothelin Effects (2 papers). David Brott is often cited by papers focused on Chronic Kidney Disease and Diabetes (3 papers), Acute Kidney Injury Research (3 papers) and Nitric Oxide and Endothelin Effects (2 papers). David Brott collaborates with scholars based in United States, United Kingdom and Sweden. David Brott's co-authors include Bernhard Ø. Palsson, Stylianos Andreadis, A. Oveta Fuller, Robert F. Todd, Rudy J. Richardson, Calvert Louden, Stephen T. Furlong, Ramin B. Arani, Sarah Gould and Mark Pinches and has published in prestigious journals such as The Journal of Immunology, Journal of Virology and Annals of the New York Academy of Sciences.

In The Last Decade

David Brott

26 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Brott United States 13 164 123 79 59 50 28 468
Takaaki Fukuda Japan 17 175 1.1× 241 2.0× 105 1.3× 53 0.9× 34 0.7× 52 744
Terukazu Tanaka Japan 14 184 1.1× 95 0.8× 29 0.4× 92 1.6× 41 0.8× 50 554
Daisuke Shima Japan 14 270 1.6× 36 0.3× 59 0.7× 95 1.6× 26 0.5× 27 589
D. Chimenti Italy 16 230 1.4× 243 2.0× 44 0.6× 44 0.7× 39 0.8× 24 816
Poonam Rani India 11 156 1.0× 106 0.9× 80 1.0× 29 0.5× 29 0.6× 24 459
Toshiya Okumura Japan 13 167 1.0× 136 1.1× 35 0.4× 33 0.6× 23 0.5× 16 503
Jonathan T. Beech United Kingdom 13 185 1.1× 316 2.6× 40 0.5× 49 0.8× 59 1.2× 18 665
Yongnian Liu China 15 300 1.8× 259 2.1× 40 0.5× 71 1.2× 67 1.3× 33 591
Monika Philipp Germany 11 127 0.8× 100 0.8× 37 0.5× 82 1.4× 32 0.6× 14 577

Countries citing papers authored by David Brott

Since Specialization
Citations

This map shows the geographic impact of David Brott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Brott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Brott more than expected).

Fields of papers citing papers by David Brott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Brott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Brott. The network helps show where David Brott may publish in the future.

Co-authorship network of co-authors of David Brott

This figure shows the co-authorship network connecting the top 25 collaborators of David Brott. A scholar is included among the top collaborators of David Brott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Brott. David Brott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brott, David, et al.. (2018). Are laboratory parameter (biomarker) values similar to the healthy volunteer reference range in all patient populations?. Drug Design Development and Therapy. Volume 12. 2757–2773. 1 indexed citations
2.
Brott, David, Stephen T. Furlong, Scott Adler, et al.. (2015). Characterization of renal biomarkers for use in clinical trials: effect of preanalytical processing and qualification using samples from subjects with diabetes. Drug Design Development and Therapy. 9. 3191–3191. 12 indexed citations
3.
Brott, David, Håkan Andersson, Jane Stewart, et al.. (2014). A peripherally restricted P2Y12 receptor antagonist altered rat tumor incidences with no human relevance: Mode of action consistent with dopamine agonism. Toxicology Reports. 1. 1202–1212. 12 indexed citations
4.
Brott, David, Heath C. Thomas, Michael Lawton, et al.. (2014). Evaluation of von Willebrand Factor and von Willebrand Factor Propeptide in Models of Vascular Endothelial Cell Activation, Perturbation, and/or Injury. Toxicologic Pathology. 42(4). 672–683. 16 indexed citations
5.
Brott, David, et al.. (2014). Characterization of renal biomarkers for use in clinical trials: biomarker evaluation in healthy volunteers. Drug Design Development and Therapy. 8. 227–227. 30 indexed citations
6.
Chen, Yafei, David Brott, Wei Luo, et al.. (2013). Assessment of cisplatin-induced kidney injury using an integrated rodent platform. Toxicology and Applied Pharmacology. 268(3). 352–361. 28 indexed citations
7.
Brott, David, et al.. (2013). An acute rat in vivo screening model to predict compounds that alter blood glucose and/or insulin regulation. Journal of Pharmacological and Toxicological Methods. 68(2). 190–196. 3 indexed citations
8.
Brott, David, et al.. (2012). Renal biomarker changes associated with hyaline droplet nephropathy in rats are time and potentially compound dependent. Toxicology. 303. 133–138. 4 indexed citations
9.
Brott, David, et al.. (2012). Inhibition of Oestradiol‐induced Prolactin Release in a Dual‐Cannulated Ovariectomized Rat Model by Carmoxirole, a Peripherally Restricted Dopamine Agonist. Basic & Clinical Pharmacology & Toxicology. 111(6). 411–416. 4 indexed citations
10.
Kamendi, Harriet, David Brott, Yafei Chen, et al.. (2010). Combining radio telemetry and automated blood sampling: A novel approach for integrative pharmacology and toxicology studies. Journal of Pharmacological and Toxicological Methods. 62(1). 30–39. 18 indexed citations
11.
Brott, David, Sarah Gould, H. B. Jones, et al.. (2005). Biomarkers of drug-induced vascular injury. Toxicology and Applied Pharmacology. 207(2). 441–445. 30 indexed citations
12.
Brott, David, H. B. Jones, Sarah Gould, et al.. (2005). Current status and future directions for diagnostic markers of drug-induced vascular injury. Cancer Biomarkers. 1(1). 15–28. 8 indexed citations
14.
Koller, Manfred R., et al.. (1996). flt-3 Ligand Is More Potent Than c-kit Ligand for the Synergistic Stimulation of Ex Vivo Hematopoietic Cell Expansion. Journal of Hematotherapy. 5(5). 449–459. 25 indexed citations
15.
Baragi, Vijay, David Brott, Luping Qiu, M.C. Conroy, & Narendra D. Lalwani. (1995). Immunofluorescence quantitation of stromelysin in human synovial fibroblasts by confocal laser scanning microscopy.. PubMed. 72(4). 484–90. 3 indexed citations
16.
Baragi, Vijay, David Brott, Luping Qiu, M.C. Conroy, & Narendra D. Lalwani. (1994). Confocal Laser Scanning Immunofluorescence Imaging for Quantitation of Stromelysin in Human Synovial Fibroblasts. Annals of the New York Academy of Sciences. 732(1). 348–350. 1 indexed citations
17.
Bleavins, Michael R., et al.. (1993). Flow cytometric characterization of lymphocyte subpopulations in the cynomolgus monkey (Macaca fascicularis). Veterinary Immunology and Immunopathology. 37(1). 1–13. 17 indexed citations
18.
Brott, David, et al.. (1993). Cell cycle dependent distribution of proliferating cell nuclear antigen/cyclin and cdc2‐kinase in mouse T‐lymphoma cells. Journal of Cellular Biochemistry. 52(3). 362–372. 10 indexed citations
19.
Brott, David, et al.. (1993). Comparative micronucleus quantitation in pre- and post-column fractionated mouse bone marrow by manual and flow methods. Mutation Research Letters. 302(2). 119–127. 17 indexed citations
20.
Martin, Ronald E., et al.. (1992). Differential analysis of animal bone marrow by flow cytometry. Cytometry. 13(6). 638–643. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026